Editas Medicine (EDIT) EBITDA Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) EBITDA Margin Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -33,975.00 |
| Jun 30, 2025 | -114,903.00 |
| Mar 31, 2025 | -82,056.00 |
| Dec 31, 2024 | 16,868.00 |
| Sep 30, 2024 | -10.68 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -439,132.00 |
| Dec 31, 2023 | 38,914.00 |
| Sep 30, 2023 | -82,811.00 |
| Jun 30, 2023 | -98,939.00 |
| Mar 31, 2023 | 28,632.00 |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | 64,904.00 |
| Mar 31, 2022 | 374,124.00 |
| Dec 31, 2021 | 400,750.00 |
| Sep 30, 2021 | 156,668.00 |
| Jun 30, 2021 | -1.41 Mn |
| Mar 31, 2021 | 134,077.00 |
| Dec 31, 2020 | 98,538.00 |
| Sep 30, 2020 | 111,610.00 |